Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC127553 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 61 |
0.1-0.2 | 3485 |
0.2-0.3 | 16836 |
0.3-0.4 | 9508 |
0.4-0.5 | 901 |
0.5-0.6 | 83 |
0.6-0.7 | 6 |
0.7-0.8 | 1 |
0.8-0.85 | 1 |
0.85-0.9 | 6 |
0.9-0.95 | 0 |
0.95-1 | 1 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC127553 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 67 |
0.1-0.2 | 1310 |
0.2-0.3 | 5492 |
0.3-0.4 | 1957 |
0.4-0.5 | 269 |
0.5-0.6 | 55 |
0.6-0.7 | 11 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6618 |
Remote Similarity |
NPD1823 |
Approved |
0.6618 |
Remote Similarity |
NPD1822 |
Approved |
0.6618 |
Remote Similarity |
NPD1821 |
Approved |
0.6329 |
Remote Similarity |
NPD2695 |
Approved |
0.6329 |
Remote Similarity |
NPD2697 |
Approved |
0.6329 |
Remote Similarity |
NPD2694 |
Approved |
0.6329 |
Remote Similarity |
NPD2696 |
Approved |
0.6232 |
Remote Similarity |
NPD7348 |
Clinical (unspecified phase) |
0.6027 |
Remote Similarity |
NPD6439 |
Phase 3 |
0.6 |
Remote Similarity |
NPD8143 |
Approved |
0.6 |
Remote Similarity |
NPD8144 |
Approved |
0.5854 |
Remote Similarity |
NPD7535 |
Discontinued |
0.5842 |
Remote Similarity |
NPD7912 |
Approved |
0.5842 |
Remote Similarity |
NPD7987 |
Approved |
0.5842 |
Remote Similarity |
NPD7986 |
Approved |
0.5842 |
Remote Similarity |
NPD7911 |
Approved |
0.5833 |
Remote Similarity |
NPD312 |
Clinical (unspecified phase) |
0.5753 |
Remote Similarity |
NPD3727 |
Discontinued |
0.5728 |
Remote Similarity |
NPD8040 |
Discontinued |
0.5673 |
Remote Similarity |
NPD7646 |
Clinical (unspecified phase) |
0.5673 |
Remote Similarity |
NPD7989 |
Approved |
0.5673
|
Remote Similarity |
NPD7990 |
Approved |